Trials / Completed
CompletedNCT02002858
Smoking Cessation for Depression and Anxiety Treatment
Integrated Smoking Cessation Treatment for Emotional Dysregulation
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Houston · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation, and anxiety and depression management treatment program (SDAT). Both treatments also utilize nicotine replacement therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicotine Patch | |
| BEHAVIORAL | Depression and Anxiety Smoking Cessation Treatment | Cognitive-behavioral treatment program that blends smoking cessation, anxiety, and depression management/reduction treatment strategies |
| BEHAVIORAL | Educational-Support Psychotherapy | Educational-based psychotherapy and standard smoking cessation treatment program |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-11-01
- Completion
- 2017-05-01
- First posted
- 2013-12-06
- Last updated
- 2017-07-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02002858. Inclusion in this directory is not an endorsement.